Robert Ticktin SEC EDGAR Filings (CIK 0001613482)

SEC EDGAR filings, ownership reports, and insider transactions for Robert Ticktin.

Business address
C/O Epirus Biopharmaceuticals, Inc., 699 Boylston Street 8 Th Floor, Boston, MA, 02116
Top holdings (ownership)
PMVP
Get insider transactions for this reporting owner
Robert Ticktin has filed 9 SEC EDGAR filings since 15 Jul 2014

Latest Filings

Recent SEC filings for Robert Ticktin including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 03 Jul 2025 01 Jul 2025 001-39539
3 Open 3 document View SEC filing for 3 23 Apr 2025 21 Apr 2025 001-39539
4 Open 4 document View SEC filing for 4 4 31 May 2016 27 May 2016 000-51171
4 Open 4 document View SEC filing for 4 4 01 Mar 2016 27 Feb 2016 000-51171
4 Open 4 document View SEC filing for 4 4 22 Dec 2015 21 Dec 2015 000-51171
4 Open 4 document View SEC filing for 4 4 03 Nov 2015 02 Nov 2015 000-51171
4 Open 4 document View SEC filing for 4 4 02 Mar 2015 27 Feb 2015 000-51171
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 17 Jul 2014 16 Jul 2014 000-51171
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 15 Jul 2014 15 Jul 2014 000-51171

About this filer

Robert Ticktin files with the SEC under CIK 0001613482. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages